Literature DB >> 9635611

Helicobacter pylori infection and peptic ulcer disease in cirrhosis.

C J Tsai1.   

Abstract

An increased frequency of peptic ulcer disease is noted in patients with cirrhosis, but the role of H. pylori in this disorder remains to be determined. The diagnosis of cirrhosis was confirmed by a combination of clinical, biochemical, radiological, and histological methods. The severity of cirrhosis was assessed by Pugh's modification of Child's criteria. Upper gastrointestinal endoscopy was performed consecutively to evaluate the presence of varices and gastroduodenal mucosa. H. pylori status was assessed by histology, urease test, and serology. In all, 130 patients with cirrhosis were recruited into the study; there were 86 males and 44 females with a mean (SD) age of 54.4 (12.7) years. The H. pylori prevalence was 76.2%. There was no difference in age between the H. pylori-positive and -negative cirrhotics (P = 0.29). The H. pylori prevalence revealed no difference among cirrhotics with Child A (77.8%), Child B (72.9%), and Child C (78.6%) (P = 0.8), and neither was there a difference in H. pylori prevalence in cirrhotics with and without congestive gastropathy (77% vs 73.7%, P = 0.84). The prevalence of H. pylori in cirrhotics with and without varices did not show a statistical difference (75% vs 81.8%, P = 0.68). There also was no difference in the H. pylori prevalence between cirrhotic patients with and without peptic ulcers (84.4% vs 69.7%, P = 0.09). In conclusion, the prevalence of H. pylori or peptic ulcer is independent of the severity of cirrhotic liver disease. The association between H. pylori infection and peptic ulcer disease is weak in cirrhosis.

Entities:  

Mesh:

Year:  1998        PMID: 9635611     DOI: 10.1023/a:1018899506271

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Gastric secretion in human hepatic cirrhosis.

Authors:  J D OSTROW; R J TIMMERMAN; S J GRAY
Journal:  Gastroenterology       Date:  1960-03       Impact factor: 22.682

2.  Chronic disease in former college students; 13. Early precursors of peptic ulcer.

Authors:  R S Paffenbarger; A L Wing; R T Hyde
Journal:  Am J Epidemiol       Date:  1974-10       Impact factor: 4.897

3.  Cigarettes, alcohol, coffee and peptic ulcer.

Authors:  G D Friedman; A B Siegelaub; C C Seltzer
Journal:  N Engl J Med       Date:  1974-02-28       Impact factor: 91.245

4.  Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively.

Authors:  M Rabinovitz; Y K Yoo; R R Schade; V J Dindzans; D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

5.  Morphology of gastric microcirculation in cirrhosis.

Authors:  M Hashizume; K Tanaka; K Inokuchi
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

6.  Frequency of upper gastrointestinal lesions in patients with liver cirrhosis.

Authors:  C Sacchetti; M Capello; P Rebecchi; L Roncucci; G Zanghieri; A Tripodi; M Ponz de Leon
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

7.  Smoking, alcohol, coffee, and familial factors: any associations with peptic ulcer disease? A clinically and radiologically prospective study.

Authors:  H Ostensen; T E Gudmundsen; M Ostensen; P G Burhol; O Bonnevie
Journal:  Scand J Gastroenterol       Date:  1985-12       Impact factor: 2.423

8.  Intravascular oesophageal variceal pressure (IOVP) assessed by endoscopic fine needle puncture under basal conditions, Valsalva's manoeuvre and after glyceryltrinitrate application.

Authors:  M Staritz; T Poralla; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

9.  Peptic ulceration in patients with chronic liver disease.

Authors:  A P Kirk; J S Dooley; R H Hunt
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

10.  Smoking, alcohol, analgesics, and chronic duodenal ulcer. A controlled study of habits before first symptoms and before diagnosis.

Authors:  D W Piper; R Nasiry; J McIntosh; C M Shy; J Pierce; K Byth
Journal:  Scand J Gastroenterol       Date:  1984-11       Impact factor: 2.423

View more
  13 in total

1.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

2.  Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Gastric epithelial cell proliferation in patients with liver cirrhosis.

Authors:  A Zullo; A Romiti; V Rinaldi; A Vecchione; C Hassan; S Winn; S Tomao; A F Attili
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

4.  Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease.

Authors:  I Nilsson; S Lindgren; S Eriksson; T Wadström
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

5.  Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis.

Authors:  Gabriele I Kirchner; Winfried Beil; Joerg S Bleck; Micheal P Manns; Siegfried Wagner
Journal:  Int J Clin Exp Med       Date:  2010-12-25

Review 6.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1.

Authors:  Sharad Sharma; Ahmet Gurakar; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2007-11-09       Impact factor: 3.199

Review 7.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

8.  Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage Adjustments.

Authors:  Fiona V Bϋdingen; Daniel Gonzalez; Amelia N Tucker; Hartmut Derendorf
Journal:  Ther Adv Infect Dis       Date:  2014-02-01

9.  Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis.

Authors:  Dong Joon Kim; Hak Yang Kim; Sung Jung Kim; Tae Ho Hahn; Myoung Kuk Jang; Gwang Ho Baik; Jin Bong Kim; Sang Hoon Park; Myung-Seok Lee; Choong Kee Park
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 3.165

10.  Gastric tissue oxidative changes in portal hypertension and cirrhosis.

Authors:  Yuksel Seckin; Murat M M Harputluoglu; Kadir Batcioglu; Melih Karincaoglu; Bulent Yildirim; Ramazan I Oner; Burcin Uyumlu; Nurettin Aydogdu; Fatih Hilmioglu
Journal:  Dig Dis Sci       Date:  2007-03-08       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.